Opportunity and Strategy Analysis
This report focuses on identifying opportunities and strategies for investing in the global surgical dressings market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter’s Fiver Forces analysis.
Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the surgical dressings industry and market. All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global surgical dressings industry.
Âé¶¹Ô´´ Coverage & Overview
The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global surgical dressings market is expected to reach $11.53 billion by 2033, growing by 6.7% annually over the coming years.
Segmentation Analysis
Highlighted with 89 tables and 97 figures, this 191-page report represents a 360-degree view on the global market with extensively detailed segmentations Product, Application, End User, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.
By Product
• Primary Dressing
o Film Dressing
o Hydrocolloid Dressing
o Foam Dressing
o Hydrogel Dressing
o Alginate Dressing
o Soft Silicone Dressing
o Composite Dressing
• Secondary Dressing
o Bandages
 Muslin Bandage Rolls
 Elastic Bandage Rolls
 Orthopedic Bandages
 Elastic Plaster Bandages
 Triangular Bandages
 Other Bandages
o Absorbents
o Adhesive Tapes
o Protectives
o Other Secondary Dressings
• Other Products
By Application
• Cardiovascular Diseases
• Diabetes-based Surgeries
• Organ Transplants
• Ulcers
• Burns
• Other Applications
By End User
• Hospitals
• Ambulatory Surgery Centers
• Specialty Clinics
• Âé¶¹Ô´´ Healthcare
• Other End Users
By Region
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
The breakdown of all regional markets by country and the breakdown of each national market by Product, Application, and End User over the forecast years are also included.
Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
• 3M Company
• Acelity L.P. Inc.
• Advancis Medical UK
• Alliqua Biomedical, Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Cardinal Health Inc.
• Coloplast A/S
• ConvaTec Group PLC
• DeRoyal Industries Inc.
• Essity Aktiebolag AB
• Hollister Incorporated
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson
• Lohmann & Rauscher International GmbH & Co. KG
• Medline Industries, Inc.
• Medtronic PLC
• Mölnlycke Health Care AB
• Organogenesis Holdings Inc.
• Paul Hartmann AG
• Smith & Nephew plc
• Winner Medical Co., Ltd.
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Âé¶¹Ô´´ Research Methodology 13
1.2.2 Âé¶¹Ô´´ Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Âé¶¹Ô´´ Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Âé¶¹Ô´´ Overview and Dynamics 20
2.1 Âé¶¹Ô´´ Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Âé¶¹Ô´´ 25
2.1.3 Impact of Russia-Ukraine Conflict 27
2.1.4 Impact of Israel-Palestine War 29
2.2 Major Growth Drivers 30
2.3 Âé¶¹Ô´´ Restraints and Challenges 35
2.4 Emerging Opportunities and Âé¶¹Ô´´ Trends 38
2.5 Porter’s Fiver Forces Analysis 41
3 Segmentation of Global Âé¶¹Ô´´ by Product 45
3.1 Âé¶¹Ô´´ Overview by Product 45
3.2 Primary Dressing 48
3.2.1 Film Dressing 50
3.2.2 Hydrocolloid Dressing 51
3.2.3 Foam Dressing 52
3.2.4 Hydrogel Dressing 53
3.2.5 Alginate Dressing 54
3.2.6 Soft Silicone Dressing 55
3.2.7 Composite Dressing 56
3.3 Secondary Dressing 57
3.3.1 Bandages 59
3.3.2 Absorbents 60
3.3.3 Adhesive Tapes 61
3.3.4 Protectives 62
3.3.5 Other Secondary Dressings 63
3.4 Other Products 64
4 Segmentation of Global Âé¶¹Ô´´ by Application 65
4.1 Âé¶¹Ô´´ Overview by Application 65
4.2 Cardiovascular Diseases 68
4.3 Diabetes-based Surgeries 69
4.4 Organ Transplants 70
4.5 Ulcers 71
4.6 Burns 72
4.7 Other Applications 73
5 Segmentation of Global Âé¶¹Ô´´ by End User 74
5.1 Âé¶¹Ô´´ Overview by End User 74
5.2 Hospitals 77
5.3 Ambulatory Surgery Centers 78
5.4 Specialty Clinics 79
5.5 Âé¶¹Ô´´ Healthcare 80
5.6 Other End Users 81
6 Segmentation of Global Âé¶¹Ô´´ by Region 82
6.1 Geographic Âé¶¹Ô´´ Overview 2023-2033 82
6.2 North America Âé¶¹Ô´´ 2023-2033 by Country 87
6.2.1 Overview of North America Âé¶¹Ô´´ 87
6.2.2 U.S. 91
6.2.3 Canada 94
6.2.4 Mexico 96
6.3 European Âé¶¹Ô´´ 2023-2033 by Country 98
6.3.1 Overview of European Âé¶¹Ô´´ 98
6.3.2 Germany 102
6.3.3 U.K. 104
6.3.4 France 106
6.3.5 Spain 108
6.3.6 Italy 110
6.3.7 Russia 112
6.3.8 Rest of European Âé¶¹Ô´´ 114
6.4 Asia-Pacific Âé¶¹Ô´´ 2023-2033 by Country 116
6.4.1 Overview of Asia-Pacific Âé¶¹Ô´´ 116
6.4.2 Japan 120
6.4.3 China 123
6.4.4 Australia 125
6.4.5 India 127
6.4.6 South Korea 129
6.4.7 Rest of APAC Region 131
6.5 South America Âé¶¹Ô´´ 2023-2033 by Country 133
6.5.1 Argentina 137
6.5.2 Brazil 139
6.5.3 Chile 141
6.5.4 Rest of South America Âé¶¹Ô´´ 143
6.6 MEA Âé¶¹Ô´´ 2023-2033 by Country 144
6.6.1 UAE 148
6.6.2 Saudi Arabia 150
6.6.3 South Africa 152
6.6.4 Other National Âé¶¹Ô´´s 154
7 Competitive Landscape 155
7.1 Overview of Key Vendors 155
7.2 New Product Launch, Partnership, Investment, and M&A 158
7.3 Company Profiles 159
3M Company 159
Acelity L.P. Inc. 161
Advancis Medical UK 162
Alliqua Biomedical, Inc. 163
B. Braun Melsungen AG 164
Baxter International Inc. 165
Cardinal Health Inc. 166
Coloplast A/S 167
ConvaTec Group PLC 168
DeRoyal Industries Inc. 169
Essity Aktiebolag AB 170
Hollister Incorporated 171
Integra LifeSciences Holdings Corporation 172
Johnson & Johnson 173
Lohmann & Rauscher International GmbH & Co. KG 174
Medline Industries, Inc. 175
Medtronic PLC 176
Mölnlycke Health Care AB 177
Organogenesis Holdings Inc. 178
Paul Hartmann AG 179
Smith & Nephew plc 180
Winner Medical Co., Ltd. 181
8 Investing in Surgical Dressings Industry: Risk Assessment and Management 182
8.1 Risk Evaluation of Global Âé¶¹Ô´´ 182
8.2 Critical Success Factors (CSFs) 188
RELATED REPORTS 191
Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
• 3M Company
• Acelity L.P. Inc.
• Advancis Medical UK
• Alliqua Biomedical, Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Cardinal Health Inc.
• Coloplast A/S
• ConvaTec Group PLC
• DeRoyal Industries Inc.
• Essity Aktiebolag AB
• Hollister Incorporated
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson
• Lohmann & Rauscher International GmbH & Co. KG
• Medline Industries, Inc.
• Medtronic PLC
• Mölnlycke Health Care AB
• Organogenesis Holdings Inc.
• Paul Hartmann AG
• Smith & Nephew plc
• Winner Medical Co., Ltd.
Ìý
Ìý
*If Applicable.